Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediVera Rx is a specialty pharmacy subsidiary of Centene Corporation that provides comprehensive medication management for patients with complex, chronic conditions. Formerly known as AcariaHealth, the company was rebranded in 2024 to align with Centene's broader healthcare services strategy. The organization focuses on high-touch clinical support, offering personalized care plans, adherence programs, and financial assistance coordination. MediVera Rx manages a wide array of specialty drugs across therapeutic areas such as oncology, multiple sclerosis, hepatitis C, and rare diseases. By leveraging advanced data analytics and clinical expertise, the company aims to improve patient outcomes while managing the total cost of care for payors. The pharmacy operates multiple dispensing locations and provides nationwide distribution services to ensure timely access to critical therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediVera Rx.